Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - OTHER CURRENT LIABILITIES
Other Current Liabilities IBRX - ImmunityBio, Inc.
43.8 M
LAST VALUE
-8.46%
2 YEAR CAGR
13.28%
5 YEAR CAGR
44.21%
10 YEAR CAGR